SARS-CoV-2 In article number 2311537 by Jincun Zhao, Xun Sun, and co-workers, a specific ACE2-binding peptide with a superior antiviral activity was identified and used to modified the inhaled nanoemulsions. The inhaled remdesivir nanoemulsions strongly inhibit SARS-CoV-2 not only by blocking the binding of virus to host cells at the cell surface but also restricting virus replication intracellularly.
Inducing immune tolerance through repeated administration of self-antigens is a promising strategy for treating rheumatoid arthritis (RA), and current research indicates that coadministration of immunomodulators can further orchestrate the tolerogenic response. However, most of the clinical trials based on tolerance induction have negligible therapeutic effects. Peripheral lymphoid organs play critical roles in immunotherapy. Here, we design an engineered nanoemulsion for targeted codelivery of self-antigens and an immunomodulator to ectopic lymphoid structures (ELSs) in inflamed joints of RA. Namely, a citrullinated multiepitope self-antigen (CitP) and rapamycin are incorporated into the nanoemulsions (NEs@CitP/Rapa), which are fabricated by a facial method using commercialized pharmaceutical excipients. After intravenous administration, the nanoemulsion shows satisfactory accumulation in the inflamed paws and provides enhanced anti-inflammatory effect in various experimental murine models of RA. Our study provides a promising targeting strategy to induce immune tolerance for the treatment of RA.
In present study, we report on bone marrow (BM) mesenchymal stem cells (MSCs) that are isolated from giant pandas. Cells were collected from the BM of two stillborn giant pandas. The cells were cultured and expanded in 10% fetal bovine serum medium. Cell morphology was observed under an inverted microscopy, and the proliferation potential of the cells was evaluated by counting cell numbers for eight consecutive days. Differentiation potentials of the cells were determined by using a variety of differentiation protocols for osteocytes, adipocytes, neuron cells, and cardiomyocytes. Meanwhile, the specific gene expressions for MSCs or differentiated cells were analyzed by RT-PCR. The isolated cells exhibited a fibroblast-like morphology; expressed mesenchymal specific markers such as cluster of differentiation 73 (CD73), SRY (sex determining region Y)-box 2 (SOX-2), guanine nucleotide-binding protein-like 3 (GNL3), and stem cell factor receptor (SCFR); and could be differentiated into osteocytes and adipocytes that were characterized by Alizarin Red and Oil Red O staining. Under appropriate induction conditions, these cells were also able to differentiate into neuroglial-like or myocardial-like cells that expressed specific myocardial markers such as GATA transcription factors 4 (GATA-4), cardiac troponin T (cTnT), and myosin heavy chain 7B (MYH7B), or neural specific markers such as Nestin and glial fibrillary acidic protein (GFAP). This study demonstrated stem cells recovery and growth from giant pandas. The findings suggest that cells isolated from the BM of giant pandas have a high proliferative capacity and multiple differentiation potential in vitro which might aid conservation efforts.
Abstract Electrolyte is critical for the electrochemical properties of potassium‐ion batteries. The high‐concentration electrolyte has achieved significant effects in inhibiting the growth of dendrites and improving the cycle life of potassium ion batteries. However, the application remains challenging owing to the issues of high viscosity, low conductivity and poor electrode wettability. Herein, a fluorinated localized high concentration electrolyte (LHCE) based on potassium bis(fluorosulfonyl) imide/dimethoxyethane is designed for use in K‐ion batteries. The electrolyte structure, interfacial mechanism and diffusion kinetics are analyzed systematically through physical/electrochemical characterization and molecular dynamics simulations. The LHCE is proven to have excellent oxidation stability, low flammability, and excellent electrode wettability. Furthermore, the LHCE is investigated in a half‐cell assembled by using polyimide‐derived nitrogen doped carbon material as an anode, which exhibits a reversible capacity of 169 mAh g −1 and high‐capacity retention upon 200 cycles at a current rate of 100 mA g −1 . Fundamental mechanism on enhanced cycling stability of the carbon anodes using optimized LHCE is also investigated. This work demonstrates an example of developing new electrolytes for high performance potassium ion batteries, and also provides theoretical guidance and significant reference for electrode interphase design and engineering.
Triple-negative breast cancer is often aggressive and resistant to various cancer therapies, especially corresponding targeted drugs. It is shown that targeted delivery of chemotherapeutic drugs to tumor sites could enhance treatment outcome against triple-negative breast cancer. In this study, we exploited the active tumor-targeting capability of macrophages by loading doxorubicin-carrying liposomes on their surfaces via biotin–avidin interactions. Compared with conventional liposomes, this macrophage–liposome (MA-Lip) system further increased doxorubicin accumulation in tumor sites, penetrated deeper into tumor tissue, and enhanced antitumor immune response. As a result, the MA-Lip system significantly lengthened the survival rate of 4T1 cell-bearing mice with low toxicity. Besides, the MA-Lip system used highly biocompatible and widely approved materials, which ensured its long-term safety. This study provides a system for triple-negative breast cancer treatment and offers another macrophage-based strategy for tumor delivery.